PTEN is one of the most frequently mutated or silenced tumor suppressors in human cancer; PTEN antagonizes the PI3K-AKT pathway [18] and is known to modulate VEGF mediated angiogenesis via the down-regulation of the PI3K/AKT pathway in many solid tumors [19]. This evidence concerns the gene VEGFA and neoplasm.